Loomis, Sayles & Company’s BioTelemetry, Inc. BEAT Stock Holding History

Loomis, Sayles & Company’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-742,000	Closed	-$53.5M	–	927
2020 Q4	$53.5M	Sell	742,000 -4,412	-0.6%	-$231K	0.07%	122
2020 Q3	$34M	Buy	746,412 +14,153	+2%	+$592K	0.05%	152
2020 Q2	$33.1M	Buy	732,259 +63,469	+9%	+$2.84M	0.05%	144
2020 Q1	$25.8M	Buy	668,790 +77,376	+13%	+$3.56M	0.05%	129
2019 Q4	$27.4M	Buy	591,414 +64,897	+12%	+$2.81M	0.05%	164
2019 Q3	$21.4M	Buy	526,517 +59,724	+13%	+$2.58M	0.04%	199
2019 Q2	$22.5M	Buy	466,793 +22,858	+5%	+$1.2M	0.04%	196
2019 Q1	$27.8M	Sell	443,935 -23,331	-5%	-$1.6M	0.05%	149
2018 Q4	$27.9M	Buy	467,266 +107,133	+30%	+$6.43M	0.07%	126
2018 Q3	$23.2M	Buy	+360,133	New	+$20.1M	0.05%	193

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.69B AUM 46.33% 1-Year Est. Return

Loomis, Sayles & Company's BEAT Position: Q1 2021 in Review

Loomis, Sayles & Company sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 742,000 shares — an estimated $53.5M sold.

Loomis, Sayles & Company first reported a position in BEAT in Q3 2018 and held it in 10 quarters. The position peaked at $53.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Loomis, Sayles & Company reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Loomis, Sayles & Company sold 742,000 BioTelemetry, Inc. shares in Q1 2021, an estimated $53.5M.
Loomis, Sayles & Company first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 10 quarters.
Loomis, Sayles & Company's BioTelemetry, Inc. position peaked at $53.5M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Loomis, Sayles & Company's 13F filing for Q1 2021, filed 17 May 2021.